Investor Relations

Investor Relations

Corporate Profile

Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders. We commercialize a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets.

Our prescription WatchPAT family of products, which utilizes the PAT signal, is designed to enable patients suspected to have sleep related breathing disorders to easily conduct sleep apnea tests in the comfort of their homes in accordance with a physician’s instructions, as authorized by qualified medical personnel while delivering the treating physicians with comprehensive, accurate and reliable results to aid in the diagnosis of sleep apnea.

 
Stock Information
Press Releases
Jun
2021
Itamar Medical Launches Enhancements to WatchPAT™ Product Line at SLEEP 2021
May
2021
Itamar Medical Appoints Brad Fluegel to its Board of Directors
May
2021
Itamar Medical Reports First Quarter 2021 Results
May
2021
Itamar Medical’s WatchPAT® Technology Featured in Ladenburg Thalmann Healthcare Symposia Call Series
May
2021
Itamar Medical to Report First Quarter Financial Results and Host Conference Call on Wednesday, May 19, 2021
Apr
2021
Itamar Medical Provides Highlights of Recent Survey in Sleep Test Market
Investor Events
May
2021
Q1 2021 Itamar Medical Ltd. Earnings Conference Call
May
2021
Ladenburg Thalmann Healthcare Symposium Call Series
Mar
2021
41st Annual Cowen Health Care Conference
Mar
2021
Q4 2020 Itamar Medical Ltd. Earnings Conference Call
Investor Presentations
Management